Media Centre
Latest press releases
-
AstraZeneca China President currently under investigation
-
Fasenra approved in the EU for eosinophilic granulomatosis with polyangiitis
-
Wainzua (eplontersen) recommended for approval in the EU by CHMP for the treatment of adult patients with polyneuropathy associated with hereditary transthyretin-mediated amyloidosis
-
AstraZeneca advances science of infectious disease protection at IDWeek 2024
-
Enhertu approved in China as first HER2-directed therapy for patients with HER2-mutant metastatic non-small cell lung cancer
Medical Releases
These press releases are specifically for health specialist/medical media and are not for consumer press.
